Fmoc-L-Glu-pNA

Fmoc-L-Glu-pNA is an Fmoc-protected L-glutamate derivative bearing a p-nitroanilide leaving group on the side chain, combining a chiral amino acid backbone with an activated amide functionality. The molecule contains an Fmoc carbamate at the alpha-amino position, a side-chain carboxyl converted to a p-nitroanilide (Glu-pNA), and a stereogenic center that preserves the L-configuration for stereochemically defined peptide coupling. The p-nitroanilide chromophore provides a measurable electronic signature, while the glutamate-derived side-chain amide can participate in controlled transformations during derivatization and peptide-related synthesis. The protected amino acid architecture supports orthogonal deprotection and downstream conversion into peptide building blocks, biochemical probes, and industrially relevant intermediates for fine chemical manufacturing.

1. Peptide Synthesis

Fmoc-L-Glu-pNA is used in peptide chemistry where the Fmoc-protected alpha-amino group enables standard solid-phase or solution-phase peptide coupling after orthogonal Fmoc removal. The glutamate side chain is already functionalized as a p-nitroanilide, which can be leveraged to generate defined Glu-containing sequences or to prepare side-chain-modified analogs that retain a chromogenic handle for monitoring. The preserved L-stereochemistry supports stereochemically consistent incorporation into peptide scaffolds and minimizes epimerization risk during peptide assembly. Downstream, the resulting peptide intermediates can be converted into further derivatized glutamate residues for library synthesis and method development in amino acid chemistry.

2. Enzyme Assays

Fmoc-L-Glu-pNA is applied in biochemical research and analytical screening as a glutamate-targeting chromogenic substrate or reporter intermediate, where the p-nitroanilide moiety enables spectrophotometric readout upon cleavage. The side-chain glutamate architecture aligns with enzyme active-site recognition motifs that accommodate glutamyl residues, while the Fmoc group provides a stable, protected form during handling and preparative steps. The defined stereochemistry and amide linkage geometry support reproducible substrate behavior in enzyme studies focused on protease, peptidase, or related catalytic systems that process glutamyl-containing substrates. The chromophore-bearing product formation can be used to generate assay standards and to support structure-function investigations of substrate specificity in biochemical research workflows.

3. Amino Acid Derivatization

Fmoc-L-Glu-pNA serves as a protected amino acid derivative for side-chain functionalization strategies in synthetic organic chemistry, using its glutamate-derived amide as a manipulable intermediate. The Fmoc carbamate enables controlled deprotection to reveal the alpha-amino group for subsequent coupling, while the p-nitroanilide functionality can be transformed into alternative side-chain derivatives through selective cleavage or conversion routes compatible with amino acid chemistry. The combination of a chiral center, a protected amine, and an activated aromatic amide supports stepwise construction of C- and N-terminally defined intermediates for peptidomimetic and amino acid analog synthesis. Downstream utility includes preparation of Glu-based building blocks for SAR studies, chemical biology probes, and process chemistry intermediates used in fine chemical production.

4. Analytical Research Standards

Fmoc-L-Glu-pNA is suitable for analytical research where the p-nitroanilide chromophore provides a strong UV-Vis response for monitoring reactions, tracking deprotection events, or confirming formation of glutamate-derived derivatives. The Fmoc-protected framework can be used to generate reference materials that distinguish protected versus deprotected amino acid states during method development and impurity profiling. The molecule's well-defined stereochemistry and functional-group pattern support reproducible calibration and comparison across chromatographic or spectrometric workflows. The resulting analytical standards can be employed to support quality control of peptide building block preparation, side-chain derivatization steps, and biochemical reagent characterization.

5. Pharmaceutical Manufacturing Intermediates

Fmoc-L-Glu-pNA can be incorporated into pharmaceutical intermediate preparation pipelines where Fmoc-protected amino acid derivatives are used to construct peptide-like fragments and glutamate-containing motifs under controlled synthetic conditions. The alpha-amino Fmoc protection supports orthogonal protection management during multi-step synthesis, while the glutamate side-chain amide provides a defined functional handle for conversion into other protected or activated forms used in downstream fragment coupling. The p-nitroanilide group may serve as a process-compatible tag for monitoring conversion or for generating intermediates that can be further transformed into non-chromophoric glutamate derivatives. The resulting workflow compatibility aligns with industrial fine chemical synthesis practices that rely on chiral amino acid building blocks and robust protecting-group strategies.

1. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function

2. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate

3. TMEM16F and dynamins control expansive plasma membrane reservoirs

4. A possible role of tachykinin-related peptide on an immune system activity of mealworm beetle, Tenebrio molitor L

5. Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis